{"entity":{"id":"idea-tr1-mobile-research-units","kind":"idea","name":"Mobile research units bring trial visits to rural towns","aka":[],"tldr":"A van equipped for blood draws, ECGs, questionnaires and drug hand-over could visit rural towns on a schedule so trial participants there do not have to travel hours each cycle.","summary":"Mobile units staffed by research nurses under a hub site's oversight run scheduled circuits through rural areas, performing protocol assessments, sampling and oral drug dispensing, linked by telehealth to the investigator. Mobile screening units and mobile stroke units are precedents; trial-specific units have been piloted in the US.","asOf":"2026-09-08","links":[{"label":"Bottleneck evidence (Trials enrol too few, too slowly): Unger et al., Systematic review of barriers to cancer trial participation (JNCI 2019)","url":"https://doi.org/10.1093/jnci/djy221"}],"tags":[],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["nci"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":["b-trial-enrolment","b-trial-diversity"],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"hypothesis":"Regions served by mobile research units will enrol rural patients into interventional trials at a rate approaching that of urban patients, from a baseline of a small fraction.","rationale":"Rural cancer patients have worse outcomes and lower trial participation; distance is the dominant barrier. Bringing the trial to the patient removes it for most non-infusion visits.","test":"Fund two units serving a defined rural catchment and compare rural enrolment rates with matched catchments without units over two years.","maturity":"speculative","actor":"philanthropy","cost":"medium","horizonYears":3},"route":"/ideas/idea-tr1-mobile-research-units/","neighbours":{"institution":[{"id":"nci","kind":"institution","name":"National Cancer Institute (NIH)","route":"/institutions/nci/"}],"bottleneck":[{"id":"b-trial-diversity","kind":"bottleneck","name":"Trials do not represent the people who get cancer","route":"/bottlenecks/b-trial-diversity/"},{"id":"b-trial-enrolment","kind":"bottleneck","name":"Trials enrol too few, too slowly","route":"/bottlenecks/b-trial-enrolment/"}]}}